Senate showdown coming on DTC ad restrictions

04/13/2007 | Advertising Age (tiered subscription model)

Legislation that could restrict direct-to-consumer advertising of drugs is expected to be acted on this week by a Senate committee. One proposal would allow the FDA to ban DTC ads for the first two years of a new drug. The drug and ad industries fear the FDA would use that authority to broadly ban ads for all new drugs.

View Full Article in:

Advertising Age (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL